Literature DB >> 26878141

Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.

Susanne Schöttler1,2, Greta Becker1, Svenja Winzen1, Tobias Steinbach1, Kristin Mohr1, Katharina Landfester1, Volker Mailänder1,2, Frederik R Wurm1.   

Abstract

The current gold standard to reduce non-specific cellular uptake of drug delivery vehicles is by covalent attachment of poly(ethylene glycol) (PEG). It is thought that PEG can reduce protein adsorption and thereby confer a stealth effect. Here, we show that polystyrene nanocarriers that have been modified with PEG or poly(ethyl ethylene phosphate) (PEEP) and exposed to plasma proteins exhibit a low cellular uptake, whereas those not exposed to plasma proteins show high non-specific uptake. Mass spectrometric analysis revealed that exposed nanocarriers formed a protein corona that contains an abundance of clusterin proteins (also known as apolipoprotein J). When the polymer-modified nanocarriers were incubated with clusterin, non-specific cellular uptake could be reduced. Our results show that in addition to reducing protein adsorption, PEG, and now PEEPs, can affect the composition of the protein corona that forms around nanocarriers, and the presence of distinct proteins is necessary to prevent non-specific cellular uptake.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26878141     DOI: 10.1038/nnano.2015.330

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


  42 in total

1.  Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption.

Authors:  A Gessner; R Waicz; A Lieske; B Paulke; K Mäder; R H Müller
Journal:  Int J Pharm       Date:  2000-03-10       Impact factor: 5.875

Review 2.  The journey of a drug-carrier in the body: an anatomo-physiological perspective.

Authors:  Nicolas Bertrand; Jean-Christophe Leroux
Journal:  J Control Release       Date:  2011-10-06       Impact factor: 9.776

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.

Authors:  Jörg Kreuter; Telli Hekmatara; Sebastian Dreis; Tikva Vogel; Svetlana Gelperina; Klaus Langer
Journal:  J Control Release       Date:  2006-12-20       Impact factor: 9.776

5.  Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.

Authors:  A-M Nilselid; Pia Davidsson; Katarina Nägga; Niels Andreasen; Pam Fredman; Kaj Blennow
Journal:  Neurochem Int       Date:  2006-02-21       Impact factor: 3.921

Review 6.  Protein modification and maintenance systems as biomarkers of ageing.

Authors:  Valerie Vanhooren; Alexander Navarrete Santos; Konstantinos Voutetakis; Isabelle Petropoulos; Claude Libert; Andreas Simm; Efstathios S Gonos; Bertrand Friguet
Journal:  Mech Ageing Dev       Date:  2015-04-03       Impact factor: 5.432

Review 7.  Clusterin: the intriguing guises of a widely expressed glycoprotein.

Authors:  D E Jenne; J Tschopp
Journal:  Trends Biochem Sci       Date:  1992-04       Impact factor: 13.807

8.  Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules.

Authors:  Grit Baier; Daniela Baumann; Jörg Max Siebert; Anna Musyanovych; Volker Mailänder; Katharina Landfester
Journal:  Biomacromolecules       Date:  2012-08-10       Impact factor: 6.988

9.  Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells.

Authors:  Lars Thiele; Julia E Diederichs; Regina Reszka; Hans P Merkle; Elke Walter
Journal:  Biomaterials       Date:  2003-04       Impact factor: 12.479

10.  No diagnostic value of plasma clusterin in Alzheimer's disease.

Authors:  Edina Silajdžić; Lennart Minthon; Maria Björkqvist; Oskar Hansson
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more
  195 in total

1.  Drug delivery: Unravelling the stealth effect.

Authors:  Neville J Butcher; Gysell M Mortimer; Rodney F Minchin
Journal:  Nat Nanotechnol       Date:  2016-02-15       Impact factor: 39.213

Review 2.  Ultrasound-responsive droplets for therapy: A review.

Authors:  H Lea-Banks; M A O'Reilly; K Hynynen
Journal:  J Control Release       Date:  2018-11-29       Impact factor: 9.776

Review 3.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

4.  Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles: Implications for Tissue Binding and Tumor Penetration.

Authors:  Aniket S Wadajkar; Jimena G Dancy; Christine P Carney; Brian S Hampton; Heather M Ames; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim
Journal:  Nanomedicine       Date:  2019-06-06       Impact factor: 5.307

5.  Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Authors:  Rahul Rattan; Somnath Bhattacharjee; Hong Zong; Corban Swain; Muneeb A Siddiqui; Scott H Visovatti; Yogendra Kanthi; Sajani Desai; David J Pinsky; Sascha N Goonewardena
Journal:  Bioorg Med Chem       Date:  2017-06-30       Impact factor: 3.641

6.  PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures.

Authors:  Xueguang Lu; Ke Zhang
Journal:  Nano Res       Date:  2018-07-06       Impact factor: 8.897

7.  Probing the modulated formation of gold nanoparticles-beta-lactoglobulin corona complexes and their applications.

Authors:  Jiang Yang; Bo Wang; Youngsang You; Woo-Jin Chang; Ke Tang; Yi-Cheng Wang; Wenzhao Zhang; Feng Ding; Sundaram Gunasekaran
Journal:  Nanoscale       Date:  2017-11-23       Impact factor: 7.790

8.  C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.

Authors:  Regina Tavano; Luca Gabrielli; Elisa Lubian; Chiara Fedeli; Silvia Visentin; Patrizia Polverino De Laureto; Giorgio Arrigoni; Alessandra Geffner-Smith; Fangfang Chen; Dmitri Simberg; Giulia Morgese; Edmondo M Benetti; Linping Wu; Seyed Moein Moghimi; Fabrizio Mancin; Emanuele Papini
Journal:  ACS Nano       Date:  2018-05-23       Impact factor: 15.881

Review 9.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

10.  Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations.

Authors:  Fanfei Meng; Jianping Wang; Qineng Ping; Yoon Yeo
Journal:  Nano Lett       Date:  2019-02-07       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.